Dialysis modality, humoral response to vaccine, and SARS-CoV-2 infection risk: Comparative prospective evaluation.

Alon BnayaNaomi NacaschYael EinbinderLinda ShavitDaniel ErezMoshe ShasharAyelet GrupperSydney BenchetritOri WandKeren Cohen-Hagai

Published in: Seminars in dialysis (2023)

This study found a high antibody response rate after the third and fourth doses of BNT162b2 vaccine among dialysis patients. Hemodialysis as dialysis modality is an important predictor of COVID-19 infection, despite similar humoral responses to vaccine in peritoneal dialysis.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
immune response
respiratory syndrome coronavirus